Keybank National Association OH trimmed its position in shares of PerkinElmer, Inc. (NYSE:PKI) by 3.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,316 shares of the medical research company’s stock after selling 134 shares during the period. Keybank National Association OH’s holdings in PerkinElmer were worth $226,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its holdings in shares of PerkinElmer by 28.1% during the first quarter. Envestnet Asset Management Inc. now owns 1,979 shares of the medical research company’s stock worth $115,000 after acquiring an additional 434 shares in the last quarter. Twin Tree Management LP purchased a new stake in shares of PerkinElmer during the first quarter worth $122,000. Ameritas Investment Partners Inc. purchased a new stake in shares of PerkinElmer during the first quarter worth $152,000. LS Investment Advisors LLC raised its holdings in shares of PerkinElmer by 36.9% during the first quarter. LS Investment Advisors LLC now owns 2,817 shares of the medical research company’s stock worth $164,000 after acquiring an additional 759 shares in the last quarter. Finally, Harvest Management LLC purchased a new stake in shares of PerkinElmer during the first quarter worth $201,000. Institutional investors and hedge funds own 91.69% of the company’s stock.
In other PerkinElmer news, insider Andrew Okun sold 4,358 shares of the business’s stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $65.00, for a total transaction of $283,270.00. Following the sale, the insider now directly owns 16,799 shares of the company’s stock, valued at approximately $1,091,935. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.20% of the company’s stock.
PerkinElmer, Inc. (PKI) opened at 69.08 on Friday. PerkinElmer, Inc. has a 52-week low of $45.35 and a 52-week high of $70.16. The firm has a market capitalization of $7.61 billion, a P/E ratio of 20.83 and a beta of 0.74. The firm’s 50-day moving average is $65.89 and its 200 day moving average is $62.89.
PerkinElmer (NYSE:PKI) last issued its quarterly earnings results on Thursday, August 3rd. The medical research company reported $0.67 EPS for the quarter, hitting the consensus estimate of $0.67. PerkinElmer had a net margin of 16.80% and a return on equity of 13.44%. The firm had revenue of $547.00 million for the quarter, compared to analysts’ expectations of $554.14 million. During the same period in the previous year, the firm posted $0.67 EPS. The company’s revenue for the quarter was up 2.0% on a year-over-year basis. Equities analysts anticipate that PerkinElmer, Inc. will post $2.89 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, October 20th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, October 19th. This represents a $0.28 annualized dividend and a yield of 0.41%. PerkinElmer’s dividend payout ratio (DPR) is presently 8.46%.
ILLEGAL ACTIVITY WARNING: “Keybank National Association OH Sells 134 Shares of PerkinElmer, Inc. (PKI)” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/16/keybank-national-association-oh-sells-134-shares-of-perkinelmer-inc-pki.html.
Several analysts recently issued reports on the company. Cantor Fitzgerald reiterated a “hold” rating on shares of PerkinElmer in a report on Sunday, July 16th. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $78.00 price objective for the company in a report on Wednesday, July 19th. Piper Jaffray Companies increased their price objective on PerkinElmer to $80.00 and gave the stock an “overweight” rating in a report on Tuesday, July 25th. Wells Fargo & Company assumed coverage on PerkinElmer in a report on Thursday, July 13th. They set a “market perform” rating and a $72.00 price objective for the company. Finally, Morgan Stanley reiterated an “overweight” rating and set a $79.00 price objective (up from $73.00) on shares of PerkinElmer in a report on Monday, July 10th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $67.00.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.